Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Vitamin D3 may protect rat hair follicles from radiation damage.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Testosterone is crucial for development, growth, and various body functions in mammals.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Key proteins and pathways regulate wool fiber diameter in Alpine Merino sheep.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Iron deficiency may contribute to hair loss.

Alopecia patients have less GPER-1, which might affect hair loss.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

RXRα is crucial for proper immune response and links diet to immune function.

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.